AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Aehr Test Systems
XNAS · usd
SIC 3825 · INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
FIGI BBG001SB1CS4
55.34▼ 0.31 (-0.56%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
55.65
Day's Range
54.22 – 57.85
52-Week Range
18.70 – 147.40
Volume
1.8M
Avg Volume
2.5M
Share Statistics
Shares Outstanding
Employees
136
Exchange
XNAS
Listed
1997-08-15
Share count as of July 20, 2026

Aehr Test Systems (AEHR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Aehr Test Systems (AEHR)
What is Aehr Test Systems's Market Cap?
Aehr Test Systems's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Price / Sales?
Aehr Test Systems's Price / Sales is 36.1×, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Revenue (TTM)?
Aehr Test Systems's Revenue (TTM) is $50.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Net Income (TTM)?
Aehr Test Systems's Net Income (TTM) is -$7.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's EBITDA?
Aehr Test Systems's EBITDA is -$11.3M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Diluted EPS (TTM)?
Aehr Test Systems's Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's EBITDA Margin?
Aehr Test Systems's EBITDA Margin is -22.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · AEHRAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMay 29, 2026Feb 27, 2026Nov 28, 2025Aug 29, 2025May 30, 2025Feb 28, 2025Nov 29, 2024Aug 30, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2023Feb 28, 2023Nov 30, 2022Aug 31, 2022May 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue
YoY growth+33.7%-43.7%-26.5%-16.4%-15.1%
Cost of Revenue
Gross profit
% of revenue42.6%32.7%25.7%33.9%30.3%
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Restructuring charges
Total operating expenses
% of revenue49.0%73.7%72.8%71.0%53.1%
Income (loss) from operations
% of revenue-6.4%-41.0%-47.0%-37.1%-22.7%
Net Interest Income
Non-Operating Income (Expense)
Income (loss) before income tax benefit
Income Tax Expense
Net income (loss)
% of revenue7.4%-31.1%-32.7%-19.0%-20.6%
Basic net income (loss) per share
Diluted net income (loss) per share